These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 23537888)

  • 1. Invariant Natural Killer T-cell anergy to endogenous myelin acetyl-glycolipids in multiple sclerosis.
    Gately CM; Podbielska M; Counihan T; Hennessy M; Leahy T; Moran AP; Hogan EL; O'Keeffe J
    J Neuroimmunol; 2013 Jun; 259(1-2):1-7. PubMed ID: 23537888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation or anergy: NKT cells are stunned by alpha-galactosylceramide.
    Sullivan BA; Kronenberg M
    J Clin Invest; 2005 Sep; 115(9):2328-9. PubMed ID: 16138189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-O-acetyl-sphingosine-series myelin glycolipids: characterization of novel 3-O-acetyl-sphingosine galactosylceramide.
    Dasgupta S; Levery SB; Hogan EL
    J Lipid Res; 2002 May; 43(5):751-61. PubMed ID: 11971946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.
    Wu L; Gabriel CL; Parekh VV; Van Kaer L
    Tissue Antigens; 2009 Jun; 73(6):535-45. PubMed ID: 19392798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide.
    Hogan AE; O'Reilly V; Dunne MR; Dere RT; Zeng SG; O'Brien C; Amu S; Fallon PG; Exley MA; O'Farrelly C; Zhu X; Doherty DG
    Clin Immunol; 2011 Aug; 140(2):196-207. PubMed ID: 21493160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of a shorter duration in the state of anergy by an invariant natural killer T cell agonist enhances its efficiency of protection from type 1 diabetes.
    Tohn R; Blumenfeld H; Haeryfar SM; Veerapen N; Besra GS; Porcelli SA; Delovitch TL
    Clin Exp Immunol; 2011 Apr; 164(1):26-41. PubMed ID: 21361909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invariant NKT cell anergy is induced by a strong TCR-mediated signal plus co-stimulation.
    Iyoda T; Ushida M; Kimura Y; Minamino K; Hayuka A; Yokohata S; Ehara H; Inaba K
    Int Immunol; 2010 Nov; 22(11):905-13. PubMed ID: 21118907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of novel myelin components 3-O-acetyl-sphingosine galactosylceramides by electrospray ionization Q-TOF MS and MS/CID-MS of Li+ adducts.
    Bennion B; Dasgupta S; Hogan EL; Levery SB
    J Mass Spectrom; 2007 May; 42(5):598-620. PubMed ID: 17370250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-mannosylceramide activates type I natural killer t cells to induce tumor immunity without inducing long-term functional anergy.
    O'Konek JJ; Kato S; Takao S; Izhak L; Xia Z; Illarionov P; Besra GS; Terabe M; Berzofsky JA
    Clin Cancer Res; 2013 Aug; 19(16):4404-11. PubMed ID: 23804426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of both IL-27 and IFN-gamma after the treatment with a ligand for invariant NK T cells is responsible for the suppression of Th2 response and allergic inflammation in a mouse experimental asthma model.
    Fujita H; Teng A; Nozawa R; Takamoto-Matsui Y; Katagiri-Matsumura H; Ikezawa Z; Ishii Y
    J Immunol; 2009 Jul; 183(1):254-60. PubMed ID: 19542437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel myelin penta- and hexa-acetyl-galactosyl-ceramides: structural characterization and immunoreactivity in cerebrospinal fluid.
    Podbielska M; Dasgupta S; Levery SB; Tourtellotte WW; Annuk H; Moran AP; Hogan EL
    J Lipid Res; 2010 Jun; 51(6):1394-406. PubMed ID: 20154333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberous sclerosis 1 promotes invariant NKT cell anergy and inhibits invariant NKT cell-mediated antitumor immunity.
    Wu J; Shin J; Xie D; Wang H; Gao J; Zhong XP
    J Immunol; 2014 Mar; 192(6):2643-50. PubMed ID: 24532578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothesized role of galactocerebroside and NKT cells in the etiology of multiple sclerosis.
    Blewett MM
    Med Hypotheses; 2008; 70(4):826-30. PubMed ID: 17889444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of invariant natural killer T-cell anergy induction through intradermal delivery of alpha-galactosylceramide.
    Bontkes HJ; Moreno M; Hangalapura B; Lindenberg JJ; de Groot J; Lougheed S; van der Vliet HJ; van den Eertwegh AJ; de Gruijl TD; von Blomberg BM; Scheper RJ
    Clin Immunol; 2010 Sep; 136(3):364-74. PubMed ID: 20570567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptome and Function of Novel Immunosuppressive Autoreactive Invariant Natural Killer T Cells That Are Absent in Progressive Multiple Sclerosis.
    Carrión B; Liu Y; Hadi M; Lundstrom J; Christensen JR; Ammitzbøll C; Dziegiel MH; Sørensen PS; Comabella M; Montalban X; Sellebjerg F; Issazadeh-Navikas S
    Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34385365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression.
    Venken K; Hellings N; Hensen K; Rummens JL; Medaer R; D'hooghe MB; Dubois B; Raus J; Stinissen P
    J Neurosci Res; 2006 Jun; 83(8):1432-46. PubMed ID: 16583400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inverse association of peripheral blood CD4(+) invariant natural killer T cells with atopy in human asthma.
    Koh YI; Shim JU; Wi JO; Han ER; Jin NC; Oh SH; Park CK; Park DJ
    Hum Immunol; 2010 Feb; 71(2):186-91. PubMed ID: 19879910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profound invariant natural killer T-cell deficiency in inflammatory arthritis.
    Tudhope SJ; von Delwig A; Falconer J; Pratt A; Woolridge T; Wilson G; Isaacs JD; Ng WF
    Ann Rheum Dis; 2010 Oct; 69(10):1873-9. PubMed ID: 20444757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invariant natural killer T cells in chronic obstructive pulmonary disease.
    Chi SY; Ban HJ; Kwon YS; Oh IJ; Kim KS; Kim YI; Kim YC; Lim SC
    Respirology; 2012 Apr; 17(3):486-92. PubMed ID: 22098381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species-specific activity of glycolipid ligands for invariant NKT cells.
    Dangerfield EM; Cheng JM; Knight DA; Weinkove R; Dunbar PR; Hermans IF; Timmer MS; Stocker BL
    Chembiochem; 2012 Jun; 13(9):1349-56. PubMed ID: 22639457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.